JM

Jan Møller Mikkelsen

President and Chief Executive Officer at Ascendis Pharma A/S

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Lists including Jan

AH
AE
AF
AJ

Based in SF

3077 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

AP
Ascendis Pharma A/S

2007

  • President and Chief Executive Officer

    2007

LifeCycle Pharma A/S

2002 - 2006

  • President and Chief Executive Officer

    2002 - 2006

Maxygen, Inc.

2000 - 2002

  • President, Protein Pharmaceutical Division

    2000 - 2002

ProFound A/S

1999 - 2000

  • Co-Founder and co-Chief Executive Officer

    1999 - 2000

NN
Novo Nordisk

1989 - 1999

  • Vice President, Protein Discovery

    1991 - 1999

  • Manager, Enzyme Structure

    1989 - 1991

Nordisk Gentofte

1987 - 1989

  • Research Scientist

    1987 - 1989